Gene therapy trial for rare immune disease withdrawn before start
NCT ID NCT00778882
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This study aimed to test a gene therapy for X-linked chronic granulomatous disease (CGD), a rare immune disorder that makes patients prone to severe infections. The treatment involved taking the patient's own blood stem cells, adding a corrected gene, and returning them to the body. The study was withdrawn before any patients were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Seoul National University Hospital
Seoul, 110-744, South Korea
Conditions
Explore the condition pages connected to this study.